You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A2A receptor blockade for sepsis
SBC: Purine Pharmaceuticals Inc. Topic: NIAIDSUMMARY Sepsis is a clinical syndrome that complicates severe infectionSepsis remains the leading cause of morbidity and mortality in critically ill patientsThere are no specific FDA approved medicines for the treatment of sepsisCurrent concepts of the pathophysiology of sepsis suggest that organ failure and mortality in sepsis are caused by inappropriate regulation of the immune systemThis manife ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
A badge-like exposure device for occupational safety and epidemiological study
SBC: TF HEALTH CORPORATION Topic: RAbstract Chemical exposure poses a threat to the safety and health of each of us, especially those who work in certain industries, such as petroleum extraction and refinery facilities, mining industry, and fertilizer factories. Various sensing technologies have been developed over the past decades to address the need, but a low cost and accurate personal exposure device that can track multiple che ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
A Bedside Relational Agent to Improve Hematopoietic Cell Transplantation Outcomes in Cancer Patients
SBC: CARE.COACH CORPORATION Topic: 101Abstract Deliriuma major cause of fallscan occur in as many asof cancer patients undergoing stem cell transplantationresulting in up totimes greater chance of dyingDelirium risk can be mitigated and many other outcomes of stem cell transplants can be improved through behavioral interventions delivered at the bedside through conversationimageryand audioHowevertraditional means of delivering these i ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
A Better Mechanism for Controlled Nanopore Translocation
SBC: ELECTRONIC BIOSCIENCES, INC. Topic: 172Project Summary Enabling high accuracy nanopore based strand sequencing has the potential to improve the understanding of long range genomic relationships and processes andbased on its accessibilityenable the associated clinical and diagnostic applicationsthe fastest growing sequencing sectorUnfortunatelyit is commonplace for nanopore sequencing error rates to exceedand higher accuracy is needed t ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
A Biosynthetic Degradable Textile for Soft Tissue Reconstruction
SBC: Deep Blue Medical Advances, Inc. Topic: 300AbstractBiosynthetic or synthetic degradable hernia mesh is the fastest growing segment of the hernia mesh marketreaching$M in sales inwith Bard controllingof the US marketfollowed by GoreNovus Scientificand EthiconWhile biosynthetic mesh may be used in any type of hernia repairit is most commonly used in ventral hernia repair cases where there is an increased risk of bacterial infectionThe reason ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Ablation of the pathogenic RNA transcript associated with myotonic dystrophy, DM1
SBC: ENZERNA BIOSCIENCES LLC Topic: NIAMSABSTRACTMyotonic muscular dystrophyDMDis a genetic disorder characterized by muscle degeneration and weaknessIt is a common form of muscular dystrophy that generally begins in adulthoodUnfortunatelythere are no approved curative therapies for DMtreatments are largely palliativeThe more severe formmyotonic dystrophy typeDMis caused by theCTG n expansion in theUTR of the dystrophia myotonica protein ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
ABROGATION OF IL2 TOXICITIES BY CNI-1493
SBC: CYTOKINE NETWORK, INC. Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
ABSORBED DOSE MEASURMENTS USING POLYMER/GEL CHAMBERS
SBC: MGS RESEARCH INCORPORATED Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
ABUSE RESISTANT TRANSDERMAL BUPRENORPHINE FOR OPIATE
SBC: BIOTEK, INC. Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
Accelerate Adoption of Galaxy Pro in the Biomedical Research Marketplace
SBC: GalaxyWorks LLC Topic: NHGRIProject Summary Galactic Core LLC aims to develop a robust, scalable, and managed service for performing enterprise-grade biomedical data analysis. The service will be based on the popular open-source Galaxy application (https://galaxyproject.org/), offering unlimited data storage and compute capabilities with an extremely powerful, flexible, and collaborative environment for analyzing data. ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health